home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.240 +0.030 (+1.36%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 06, 2022

Gainers

Via Benzinga

GoodRx Holdings's Return on Invested Capital Overview ↗

December 02, 2022

Via Benzinga

Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 01, 2022

Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.

Via Benzinga

Expert Ratings for GoodRx Holdings ↗

December 01, 2022

Via Benzinga

Why GoodRx Stock Was Plunging Today ↗

November 09, 2022

Revenue continued to slide at the healthcare company.

Via The Motley Fool

GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

GDRX earnings call for the period ending September 30, 2022.

Via The Motley Fool

PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday ↗

December 01, 2022

U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗

December 01, 2022

Via Benzinga

10 Analysts Have This to Say About GoodRx Holdings ↗

November 04, 2022

Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for GoodRx Holdings ↗

October 11, 2022

GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Shares of GoodRx Holdings Fell 18.7% Lower This Week ↗

November 18, 2022

The company, which focuses on delivering prescription drug discounts, has struggled this year.

Via The Motley Fool

2 Growth Stocks Down More Than 50% From Their Highs That Could Be Hot Buys for 2023 ↗

November 16, 2022

These businesses could perform much better next year.

Via The Motley Fool

Can Doximity Stock Keep On Climbing? ↗

November 15, 2022

A positive earnings report recently pushed Doximity through the roof, but Investors want to know whether the stock can deliver long-term gains.

Via The Motley Fool

Robinhood, MicroStrategy And Other Big Losers From Wednesday ↗

November 10, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 09, 2022

Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...

Via Benzinga

GoodRx Reports Third Quarter 2022 Results

November 08, 2022

From GoodRx Holdings, Inc.

Via Business Wire

Where GoodRx Holdings Stands With Analysts ↗

November 04, 2022

Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe

November 03, 2022

From GoodRx

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗

November 04, 2022

Upgrades

Via Benzinga

GoodRx to Present at Upcoming Investor Conferences

October 27, 2022

From GoodRx Holdings, Inc.

Via Business Wire

Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022? ↗

October 16, 2022

These four tech stocks are down nearly 90%.

Via The Motley Fool

Before Pushing Others At Work, Take A Look In The Mirror ↗

October 14, 2022

Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style.

Via Investor's Business Daily

GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers

October 13, 2022

From GoodRx

Via Business Wire

GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®

October 13, 2022

From GoodRx

Via Business Wire

GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call

October 11, 2022

From GoodRx Holdings Inc.

Via Business Wire

Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's ↗

October 11, 2022

Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69...

Via Benzinga

Where GoodRx Holdings Stands With Analysts ↗

October 11, 2022

Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com